Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings ...
Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback